COMMUNIQUÉS West-GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
08/07/2024
AMF Regulated Information Montrouge, France, July 8, 2024 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a [...]
Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
08/07/2024
Informations Réglementées Montrouge, France, le 8 juillet 2024 Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : DBVT), laboratoire [...]
Travere Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
08/07/2024
SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference on Monday, July 15 [...]
Ryan Saadi Congratulates Marc Benioff on Receiving the Yale Legend in Leadership Award and Commends Yale School of Management for Recognizing the Importance of Integrating Corporate Success with Social Responsibility
08/07/2024
WARREN, N.J., July 08, 2024 (GLOBE NEWSWIRE) -- Ryan Saadi, MD, MPH, founding CEO of Tevogen Bio (“Tevogen”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, [...]
QIAGEN to enhance the identification of human remains of Indigenous people and African Americans
08/07/2024
Partnership with University of Montana drives the implementation of next-generation sequencing and forensic investigative genetic genealogy in identifying human remains // QIAGEN provides instruments, kits and training [...]
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
08/07/2024
PURCHASE, NY, July 08, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to two new employees. Effective July 1, [...]
Cartesian Therapeutics Announces New Employment Inducement Grants
08/07/2024
GAITHERSBURG, Md., July 08, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune [...]
Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call
08/07/2024
BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/07/2024
BEDFORD, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”, the “Company” ), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the [...]
Revolution Medicines to Provide Update on RMC-6236 Pancreatic Ductal Adenocarcinoma Clinical Program on July 15, 2024
08/07/2024
REDWOOD CITY, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced [...]
NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively
08/07/2024
LANGHORNE, Pa., July 08, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
Kymera Announces Expansion of KT-474 (SAR444656) HS and AD Phase 2 Studies Following Interim Review of Safety and Efficacy
08/07/2024
WATERTOWN, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein [...]
MESA LABS DECLARES QUARTERLY DIVIDEND
08/07/2024
Lakewood, Colo, July 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0. [...]
Point-of-Care Ultrasound Certification Academy and ThinkSono Announce Strategic Partnership to Enhance Deep Vein Thrombosis (DVT) Detection Skills
08/07/2024
Partnership aims to improve patient outcomes by streamlining the proficient use of POCUS making ultrasound more accessible to healthcare professionals worldwide ROCKVILLE, Md., July 08, 2024 (GLOBE NEWSWIRE) -- Inteleos [...]
Boehringer Ingelheim produces its own green energy
08/07/2024
German Vice Chancellor and Federal Minister of Economics Robert Habeck inaugurates new biomass power plant Ingelheim site can cover 95% of its energy needs from renewable sources New power plant helps achieve the [...]
Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production
08/07/2024
Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production LEUVEN, BELGIUM - July 8, 2024 – 6:30 pm , Oxurion NV (Euronext Brussels: [...]
Half-year statement of IPSEN liquidity agreement - 2024 06 30
08/07/2024
Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF PARIS, FRANCE, July 8, 2024 - Under the liquidity agreement entrusted by IPSEN SA to NATIXIS ODDO BHF, as of June 30, 2024, the following resources [...]
Bilan semestriel du contrat de liquidité d'IPSEN - 2024 06 30
08/07/2024
Bilan semestriel du contrat de liquidité entre IPSEN et NATIXIS ODDO BHF PARIS, FRANCE, le 8 juillet 2024 - Au titre du contrat de liquidité confié par IPSEN SA à NATIXIS ODDO BHF, à la date du 30 juin 2024, les [...]
Roche to reintroduce Susvimo in the US for people with neovascular age-related macular degeneration (nAMD)
08/07/2024
The FDA has approved updates to Susvimo, which will be available to US retina specialists and patients with nAMD in the coming weeks Susvimo offers the first alternative to regular eye injections that are standard of [...]

Pages